{"product_id":"textbook-of-psychiatric-epidemiology-hardback-9780470694671","title":"Textbook of Psychiatric Epidemiology (Hardback) 9780470694671","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eTextbook of Psychiatric Epidemiology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eMing T. Tsuang (Edited by), MT Tsuang (Author), Mauricio Tohen (Edited by), Peter Jones (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780470694671, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 18 April 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e664 pages\u003cbr\u003e25.4 x 19.3 x 3.8 cm, 1.415 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"The \u003ci\u003eTextbook of Psychiatric Epidemiology\u003c\/i\u003e is a timely, up-to-date, and comprehensive book covering all aspects of the science of epidemiology as related to psychiatric disorders. Overall, this is a well written, wel-organized book that I highly recommend to all psychiatrists and neuroscientists who are interested in the underpinning of psychiatric epidemiology.\" (\u003ci\u003eJournal of Clinical Psychiatry, 2013)\u003c\/i\u003e\u003cbr\u003e\u003cbr\u003e“Overall, this book provides a thorough and understandable introduction to the field of psychiatric epidemiology, suitable for students wishing to become familiar with up-to-date applications and findings in psychiatry as they relate to public health and epidemiology.”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 6 April 2012)\u003c\/p\u003e \u003cp\u003e\"This 3rd edition is a welcome return for this informative textbook, which will be of interest to a wide readership through its extensive scope. It covers a range of areas relevant to epidemiology and beyond with what is now the standard format involving expert authors or teams.\" (\u003ci\u003eActa Psychiatrica Scandinavica, 2012\u003c\/i\u003e)\u003c\/p\u003e \u003cp\u003e\"So I started this review process with a great deal of skepticism. However, during this process I have ended up reading about areas outside my own main research field with much interest, and chapters within my own areas with much pleasure and admiration for the contributions; and, I have found myself recommending individual chapters again and again to students and other people with whom I, during this period, have discussed specific projects. So, much to my own surprise, I end up warmly recommending this book to anyone who has a professional interest in the epidemiology of, and risk factors for psychiatric disorders, and a recurring need for a fast reference to a very comprehensive array of knowledge.\" http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-5215.2012.00661.x\/full\" Read the full review.\u003cbr\u003e(\u003ci\u003eActa Neuropsychiatrica, 2012\u003c\/i\u003e)\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThe new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders.  \u003cp\u003eAs in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist. The book is ideal for students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals.\u003c\/p\u003e \u003cp\u003eThe book features a new editor, Peter Jones, from the University of Cambridge, who joins the successful US team of Ming Tsuang and Mauricio Tohen.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eList of Contributors.  \u003cp\u003e\u003cb\u003e1 Introduction to epidemiologic research methods\u003c\/b\u003e (\u003ci\u003eGlyn Lewis\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e1.1 What is epidemiology?\u003c\/p\u003e \u003cp\u003e1.2 Causation in medicine.\u003c\/p\u003e \u003cp\u003e1.3 Causal inference.\u003c\/p\u003e \u003cp\u003e1.4 The future for psychiatric epidemiology.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Analysis of categorical data: The odds ratio as a measure of association and beyond\u003c\/b\u003e (\u003ci\u003eGarrett M. Fitzmaurice and Caitlin Ravichandran\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e2.1 Introduction.\u003c\/p\u003e \u003cp\u003e2.2 Inference for a single proportion.\u003c\/p\u003e \u003cp\u003e2.3 Analysis of 2 x 2 contingency tables.\u003c\/p\u003e \u003cp\u003e2.4 Analysis of sets of 2 x 2 contingency tables.\u003c\/p\u003e \u003cp\u003e2.5 Logistic regression.\u003c\/p\u003e \u003cp\u003e2.6 Advanced topics.\u003c\/p\u003e \u003cp\u003e2.7 Concluding remarks.\u003c\/p\u003e \u003cp\u003e2.8 Further reading.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Genetic epidemiology\u003c\/b\u003e (\u003ci\u003eStephen V. Faraone, Stephen J. Glatt and Ming T. Tsuang\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e3.1 Introduction.\u003c\/p\u003e \u003cp\u003e3.2 The chain of psychiatric genetic research.\u003c\/p\u003e \u003cp\u003e3.3 Psychiatric genetics and psychiatric epidemiology.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Examining gene–environment interplay in psychiatric disorders\u003c\/b\u003e (\u003ci\u003eJudith Allardyce and Jim van Os\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e4.1 Introduction.\u003c\/p\u003e \u003cp\u003e4.2 The process of genetic epidemiology.\u003c\/p\u003e \u003cp\u003e4.3 Gene–environment interplay takes different forms.\u003c\/p\u003e \u003cp\u003e4.4 Gene–environment correlation.\u003c\/p\u003e \u003cp\u003e4.5 Gene–environment interaction.\u003c\/p\u003e \u003cp\u003e4.6 Measurement of genotype, environmental exposure and pathological phenotype.\u003c\/p\u003e \u003cp\u003e4.7 Models of GxE.\u003c\/p\u003e \u003cp\u003e4.8 Which scale should we use to measure GxE?\u003c\/p\u003e \u003cp\u003e4.9 Study designs for the detection of GxE.\u003c\/p\u003e \u003cp\u003e4.10 Threats to the validity of epidemiological GxE studies.\u003c\/p\u003e \u003cp\u003e4.11 Epigenetic mechanisms.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Reliability\u003c\/b\u003e (\u003ci\u003ePatrick E. Shrout\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e5.1 Introduction.\u003c\/p\u003e \u003cp\u003e5.2 The reliability coefficient.\u003c\/p\u003e \u003cp\u003e5.3 Designs for estimating reliability.\u003c\/p\u003e \u003cp\u003e5.4 Statistical remedies for low reliability.\u003c\/p\u003e \u003cp\u003e5.5 Reliability theory and binary judgements.\u003c\/p\u003e \u003cp\u003e5.6 Reliability statistics: General.\u003c\/p\u003e \u003cp\u003e5.7 Other reliability statistics.\u003c\/p\u003e \u003cp\u003e5.8 Summary and conclusions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Moderators and mediators: Towards the genetic and environmental bases of psychiatric disorders\u003c\/b\u003e (\u003ci\u003eHelena Chmura Kraemer\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e6.1 Introduction.\u003c\/p\u003e \u003cp\u003e6.2 Current methodological barriers.\u003c\/p\u003e \u003cp\u003e6.3 Moderation, mediation and other ways in which risk factors 'work together'.\u003c\/p\u003e \u003cp\u003e6.4 Extensions.\u003c\/p\u003e \u003cp\u003e6.5 Beyond moderators and mediators.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Validity: Definitions and applications to psychiatric research\u003c\/b\u003e (\u003ci\u003eJill M. Goldstein, Sara Cherkerzian and John C. Simpson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e7.1 Introduction.\u003c\/p\u003e \u003cp\u003e7.2 Validity of a construct.\u003c\/p\u003e \u003cp\u003e7.3 Validity of the relationships between variables.\u003c\/p\u003e \u003cp\u003e7.4 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Use of register data for psychiatric epidemiology in the Nordic countries\u003c\/b\u003e (\u003ci\u003eJouko Miettunen, Jaana Suvisaari, Jari Haukka and Matti Isohanni\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e8.1 Introduction.\u003c\/p\u003e \u003cp\u003e8.2 Registers for use in psychiatric research.\u003c\/p\u003e \u003cp\u003e8.3 Register research in Denmark.\u003c\/p\u003e \u003cp\u003e8.4 Register research in Finland.\u003c\/p\u003e \u003cp\u003e8.5 Register research in Norway.\u003c\/p\u003e \u003cp\u003e8.6 Register research in Sweden.\u003c\/p\u003e \u003cp\u003e8.7 Discussion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 An introduction to mental health services research\u003c\/b\u003e (\u003ci\u003eAnna Fernandez, Alejandra Pinto-Meza, Antoni Serrano-Blanco, Jordi Alonso and Josep Maria Haro\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e9.1 Introduction.\u003c\/p\u003e \u003cp\u003e9.2 What is mental health services research?\u003c\/p\u003e \u003cp\u003e9.3 A framework for mental health services research.\u003c\/p\u003e \u003cp\u003e9.4 Key concepts in mental health services research.\u003c\/p\u003e \u003cp\u003e9.5 Examples of mental health services research studies.\u003c\/p\u003e \u003cp\u003e9.6 Conclusion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 The pharmacoepidemiology of psychiatric medications\u003c\/b\u003e (\u003ci\u003ePhilip S. Wang, Alan M. Brookhart, Christine Ulbricht and Sebastian Schneeweiss\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e10.1 Introduction.\u003c\/p\u003e \u003cp\u003e10.2 Overview of psychopharmacoepidemiology.\u003c\/p\u003e \u003cp\u003e10.3 Sources of data.\u003c\/p\u003e \u003cp\u003e10.4 Examples of recent psychopharmacoepidemiologic studies.\u003c\/p\u003e \u003cp\u003e10.5 Conclusions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Peering into the future of psychiatric epidemiology\u003c\/b\u003e (\u003ci\u003eMichaeline Bresnahan, Ezra Susser, Dana March and Bruce Link\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e11.1 Introduction.\u003c\/p\u003e \u003cp\u003e11.2 Levels of causation: A historical overview.\u003c\/p\u003e \u003cp\u003e11.3 Levels of causation.\u003c\/p\u003e \u003cp\u003e11.4 Causation over (life) time.\u003c\/p\u003e \u003cp\u003e11.5 Examples.\u003c\/p\u003e \u003cp\u003e11.6 Framing the future.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Studying the natural history of psychopathology\u003c\/b\u003e (\u003ci\u003eWilliam W. Eaton\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e12.1 Introduction.\u003c\/p\u003e \u003cp\u003e12.2 Onset.\u003c\/p\u003e \u003cp\u003e12.3 Course.\u003c\/p\u003e \u003cp\u003e12.4 Outcome.\u003c\/p\u003e \u003cp\u003e12.5 Methodological concepts for studying the natural history of psychopathology.\u003c\/p\u003e \u003cp\u003e12.6 Conclusion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Symptom scales and diagnostic schedules in adult psychiatry\u003c\/b\u003e (\u003ci\u003eJane M. Murphy\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e13.1 Introduction.\u003c\/p\u003e \u003cp\u003e13.2 North American instruments for epidemiological research.\u003c\/p\u003e \u003cp\u003e13.3 North American instruments for psychiatric services and primary care.\u003c\/p\u003e \u003cp\u003e13.4 European instruments for psychiatric services and primary care.\u003c\/p\u003e \u003cp\u003e13.5 European instruments for epidemiological research.\u003c\/p\u003e \u003cp\u003e13.6 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14\u003c\/b\u003e The National Comorbidity Survey (NCS) and its extensions (\u003ci\u003eRonald C. Kessler\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e14.1 Introduction.\u003c\/p\u003e \u003cp\u003e14.2 The baseline NCS.\u003c\/p\u003e \u003cp\u003e14.3 The NCS follow-up survey (NCS-2).\u003c\/p\u003e \u003cp\u003e14.4 The NCS replication survey (NCS-R).\u003c\/p\u003e \u003cp\u003e14.5 The NCS-R adolescent supplement (NCS-A).\u003c\/p\u003e \u003cp\u003e14.6 The WHO WMH Surveys.\u003c\/p\u003e \u003cp\u003e14.7 Overview.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Experimental epidemiology\u003c\/b\u003e (\u003ci\u003eJohn R. Geddes\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e15.1 Introduction.\u003c\/p\u003e \u003cp\u003e15.2 Limitations of non-randomised evidence.\u003c\/p\u003e \u003cp\u003e15.3 RCTs: The translation of the experimental design into the real world.\u003c\/p\u003e \u003cp\u003e15.4 Importance and control of systematic error or bias.\u003c\/p\u003e \u003cp\u003e15.5 Importance and control of random error and noise.\u003c\/p\u003e \u003cp\u003e15.6 Reporting the results of clinical trials—the CONSORT statement.\u003c\/p\u003e \u003cp\u003e15.7 Different clinical questions will prioritise control of different threats to validity and confidence.\u003c\/p\u003e \u003cp\u003e15.8 The classification of RCTs.\u003c\/p\u003e \u003cp\u003e15.9 Effectiveness trials in schizophrenia.\u003c\/p\u003e \u003cp\u003e15.10 Department of Veterans Affairs co-operative study on the cost-effectiveness of Olanzapine (Rosenheck).\u003c\/p\u003e \u003cp\u003e15.11 The clinical antipsychotic trials of intervention effectiveness (CATIE) study.\u003c\/p\u003e \u003cp\u003e15.12 Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1).\u003c\/p\u003e \u003cp\u003e15.13 European first-episode schizophrenia trial (EUFEST).\u003c\/p\u003e \u003cp\u003e15.14 The size and cost of experimental studies in psychiatry.\u003c\/p\u003e \u003cp\u003e15.15 Clinical trials in the future.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Epidemiology of Schizophrenia\u003c\/b\u003e (\u003ci\u003eWilliam W. Eaton, Chuan-Yu Chen and Evelyn J. Bromet\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e16.1 Introduction.\u003c\/p\u003e \u003cp\u003e16.2 Methods.\u003c\/p\u003e \u003cp\u003e16.3 The burden of schizophrenia.\u003c\/p\u003e \u003cp\u003e16.4 Natural history.\u003c\/p\u003e \u003cp\u003e16.5 Demographic correlates.\u003c\/p\u003e \u003cp\u003e16.6 Social risk factors.\u003c\/p\u003e \u003cp\u003e16.7 Biological risk factors.\u003c\/p\u003e \u003cp\u003e16.8 Prevention.\u003c\/p\u003e \u003cp\u003e16.9 Discussion.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Epidemiology of depressive disorders\u003c\/b\u003e (\u003ci\u003eDeborah S. Hasin, Miriam C. Fenton and Myrna M. Weissman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e17.1 Introduction.\u003c\/p\u003e \u003cp\u003e17.2 Major depression.\u003c\/p\u003e \u003cp\u003e17.3 Dysthymia.\u003c\/p\u003e \u003cp\u003e17.4 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Epidemiology of anxiety disorders\u003c\/b\u003e (\u003ci\u003eEwald Horwath, Felicia Gould and Myrna M. Weissman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e18.1 Introduction.\u003c\/p\u003e \u003cp\u003e18.2 Anxiety disorders.\u003c\/p\u003e \u003cp\u003e18.3 Panic disorder.\u003c\/p\u003e \u003cp\u003e18.4 Agoraphobia.\u003c\/p\u003e \u003cp\u003e18.5 Social phobia.\u003c\/p\u003e \u003cp\u003e18.6 Generalised anxiety disorder.\u003c\/p\u003e \u003cp\u003e18.7 Obsessive–compulsive disorder.\u003c\/p\u003e \u003cp\u003e18.8 Anxiety and affective disorders and mass disasters.\u003c\/p\u003e \u003cp\u003e18.9 Future developments.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Epidemiology of bipolar disorder in adults and children\u003c\/b\u003e (\u003ci\u003eKathleen R. Merikangas and Mauricio Tohen\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e19.1 Introduction.\u003c\/p\u003e \u003cp\u003e19.2 Epidemiology of bipolar disorder.\u003c\/p\u003e \u003cp\u003e19.3 Patterns of comorbidity of bipolar disorder.\u003c\/p\u003e \u003cp\u003e19.4 Risk Factors.\u003c\/p\u003e \u003cp\u003e19.5 Future directions.\u003c\/p\u003e \u003cp\u003e19.6 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Epidemiology of eating disorders\u003c\/b\u003e (\u003ci\u003eTracey D. Wade, Anna Keski-Rahkonen and James I. Hudson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e20.1 Introduction.\u003c\/p\u003e \u003cp\u003e20.2 Case definition.\u003c\/p\u003e \u003cp\u003e20.3 Major prevalence studies.\u003c\/p\u003e \u003cp\u003e20.4 Incidence studies.\u003c\/p\u003e \u003cp\u003e20.5 Comorbidity.\u003c\/p\u003e \u003cp\u003e20.6 Mortality from eating disorders.\u003c\/p\u003e \u003cp\u003e20.7 Risk factors.\u003c\/p\u003e \u003cp\u003e20.8 Future directions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Epidemiology of alcohol use, abuse and dependence\u003c\/b\u003e (\u003ci\u003eDeborah A. Dawson, Ralph W. Hingson and Bridget F. Grant\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e21.1 Introduction.\u003c\/p\u003e \u003cp\u003e21.2 Population estimates of per capita consumption.\u003c\/p\u003e \u003cp\u003e21.3 Survey-based estimates of the prevalence of drinking.\u003c\/p\u003e \u003cp\u003e21.4 Alcohol-related mortality and morbidity.\u003c\/p\u003e \u003cp\u003e21.5 Alcohol and injury.\u003c\/p\u003e \u003cp\u003e21.6 Alcohol and chronic disease.\u003c\/p\u003e \u003cp\u003e21.7 Diagnostic classification of alcohol use disorders.\u003c\/p\u003e \u003cp\u003e21.8 Population estimates, prevalence, incidence and natural course of alcohol use disorders.\u003c\/p\u003e \u003cp\u003e21.9 Comorbidity of DSM-IV alcohol use disorders and other psychiatric disorders.\u003c\/p\u003e \u003cp\u003e21.10 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Epidemiology of illicit drug use disorders\u003c\/b\u003e (\u003ci\u003eWilson M. Compton, Marsha F. Lopez, Kevin P. Conway and Yonette F. Thomas\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e22.1 Introduction.\u003c\/p\u003e \u003cp\u003e22.2 Drug consumption.\u003c\/p\u003e \u003cp\u003e22.3 Definitions.\u003c\/p\u003e \u003cp\u003e22.4 Rates of DSM-IV abuse and dependence.\u003c\/p\u003e \u003cp\u003e22.5 Global rates of drug use disorders.\u003c\/p\u003e \u003cp\u003e22.6 Comorbidities with psychiatric conditions.\u003c\/p\u003e \u003cp\u003e22.7 Genetic epidemiology.\u003c\/p\u003e \u003cp\u003e22.8 Future opportunities.\u003c\/p\u003e \u003cp\u003e22.9 Conclusions.\u003c\/p\u003e \u003cp\u003e22.10 Disclaimer.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 The epidemiology of personality disorders: Findings, methods and concepts\u003c\/b\u003e (\u003ci\u003eMichael J. Lyons, Beth A. Jerskey and Margo R. Genderson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e23.1 Introduction.\u003c\/p\u003e \u003cp\u003e23.2 Substantive findings.\u003c\/p\u003e \u003cp\u003e23.3 Course, prognosis and developmental issues.\u003c\/p\u003e \u003cp\u003e23.4 Treated prevalence.\u003c\/p\u003e \u003cp\u003e23.5 Prevalence of specific personality disorders.\u003c\/p\u003e \u003cp\u003e23.6 Antisocial personality disorder.\u003c\/p\u003e \u003cp\u003e23.7 Conceptual issues.\u003c\/p\u003e \u003cp\u003e23.8 Models of personality disorder.\u003c\/p\u003e \u003cp\u003e23.9 Methodological issues.\u003c\/p\u003e \u003cp\u003e23.10 Future directions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 The epidemiology of depression and anxiety in children and adolescents\u003c\/b\u003e (\u003ci\u003eKathleen Ries Merikangas and Erin F. Nakamura\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e24.1 Introduction.\u003c\/p\u003e \u003cp\u003e24.2 Magnitude of depression and anxiety in children and adolescents.\u003c\/p\u003e \u003cp\u003e24.3 Correlates and risk factors.\u003c\/p\u003e \u003cp\u003e24.4 Service patterns and impact.\u003c\/p\u003e \u003cp\u003e24.5 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Epidemiology of attention deficit hyperactivity disorder\u003c\/b\u003e (\u003ci\u003eStephen V. Faraone\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e25.1 Introduction.\u003c\/p\u003e \u003cp\u003e25.2 Prevalence of ADHD.\u003c\/p\u003e \u003cp\u003e25.3 Pharmacoeconomics of ADHD.\u003c\/p\u003e \u003cp\u003e25.4 Comorbid psychiatric disorders.\u003c\/p\u003e \u003cp\u003e25.5 Demographic risk factors.\u003c\/p\u003e \u003cp\u003e25.6 Genetic risk factors.\u003c\/p\u003e \u003cp\u003e25.7 Environmental risk factors for ADHD.\u003c\/p\u003e \u003cp\u003e25.8 Summary and conclusions.\u003c\/p\u003e \u003cp\u003e25.9 Future directions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26 The epidemiology of autism\u003c\/b\u003e (\u003ci\u003eGregory S. Liptak\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e26.1 Introduction.\u003c\/p\u003e \u003cp\u003e26.2 Background.\u003c\/p\u003e \u003cp\u003e26.3 Definition and diagnosis.\u003c\/p\u003e \u003cp\u003e26.4 Natural history.\u003c\/p\u003e \u003cp\u003e26.5 Prevalence.\u003c\/p\u003e \u003cp\u003e26.6 Risk factors.\u003c\/p\u003e \u003cp\u003e26.7 Genetic factors.\u003c\/p\u003e \u003cp\u003e26.8 Public health impact.\u003c\/p\u003e \u003cp\u003e26.9 Associations and causal factors.\u003c\/p\u003e \u003cp\u003e26.10 Future directions.\u003c\/p\u003e \u003cp\u003e26.11 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e27 Mental illness, women, mothers and their children\u003c\/b\u003e (\u003ci\u003eKathryn M. Abel and Vera A. Morgan\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e27.1 Introduction.\u003c\/p\u003e \u003cp\u003e27.2 The epidemiology of mental illness in women of reproductive age.\u003c\/p\u003e \u003cp\u003e27.3 Fertility and fecundity in women with mental illness.\u003c\/p\u003e \u003cp\u003e27.4 Maternal mental illness at the time of conception and during pregnancy.\u003c\/p\u003e \u003cp\u003e27.5 Gene–environment interactions and offspring outcomes.\u003c\/p\u003e \u003cp\u003e27.6 Obstetric complications and risk of adult onset mental disorder in offspring.\u003c\/p\u003e \u003cp\u003e27.7 Parental condition.\u003c\/p\u003e \u003cp\u003e27.8 Motherhood and perinatal mental illness.\u003c\/p\u003e \u003cp\u003e27.9 Designing studies examining the relationship between maternal mental illness and outcomes for their children.\u003c\/p\u003e \u003cp\u003e27.10 Conclusions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e28 Epidemiology of suicide and attempted suicide\u003c\/b\u003e(\u003ci\u003eDianne Currier and Maria A. Oquendo\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e28.1 Introduction.\u003c\/p\u003e \u003cp\u003e28.2 Definitions.\u003c\/p\u003e \u003cp\u003e28.3 Prevalence of suicide and attempted suicide.\u003c\/p\u003e \u003cp\u003e28.4 Risk factors for suicide and attempted suicide.\u003c\/p\u003e \u003cp\u003e28.5 Protective factors.\u003c\/p\u003e \u003cp\u003e28.6 Conclusions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e29 Epidemiology and geriatric psychiatry\u003c\/b\u003e (\u003ci\u003eCelia F. Hybels and Dan G. Blazer\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e29.1 Introduction.\u003c\/p\u003e \u003cp\u003e29.2 Issues of case identification.\u003c\/p\u003e \u003cp\u003e29.3 The distribution of cases.\u003c\/p\u003e \u003cp\u003e29.4 Aetiological studies.\u003c\/p\u003e \u003cp\u003e29.5 Outcome studies.\u003c\/p\u003e \u003cp\u003e29.6 Historical trends in the epidemiology of psychiatric disorders in late life.\u003c\/p\u003e \u003cp\u003e29.7 Use of health care services.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e30\u003c\/b\u003e \u003cb\u003eRecent epidemiological studies of psychiatric disorders in Japan\u003c\/b\u003e (\u003ci\u003eMasayoshi Kawai, Kenji J. Tsuchiya and Nori Takei\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e30.1 Introduction.\u003c\/p\u003e \u003cp\u003e30.2 Schizophrenia.\u003c\/p\u003e \u003cp\u003e30.3 Affective disorders.\u003c\/p\u003e \u003cp\u003e30.4 Autism and autism spectrum disorder.\u003c\/p\u003e \u003cp\u003e30.5 Summary.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e31 Epidemiology of migration and serious mental illness: The example of migrants to Europe\u003c\/b\u003e (\u003ci\u003eMonica Charalambides, Craig Morgan and Robin M. Murray\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e31.1 Introduction.\u003c\/p\u003e \u003cp\u003e31.2 Defining the constructs.\u003c\/p\u003e \u003cp\u003e31.3 High rates of psychosis in migrants: A genuine finding or methodological artefact?\u003c\/p\u003e \u003cp\u003e31.4 Possible explanations.\u003c\/p\u003e \u003cp\u003e31.5 Biological considerations.\u003c\/p\u003e \u003cp\u003e31.6 Cannabis use.\u003c\/p\u003e \u003cp\u003e31.7 Adverse social experiences.\u003c\/p\u003e \u003cp\u003e31.8 Mechanisms.\u003c\/p\u003e \u003cp\u003e31.9 Implications.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e32 Epidemiology of migration substance use disorder in Latin American populations and migration to the United States\u003c\/b\u003e (\u003ci\u003eMarıa Elena Medina-Mora, Guilherme Borges, Tania Real and Jorge Villatoro\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e32.1 Introduction.\u003c\/p\u003e \u003cp\u003e32.2 Definitions: What do we understand by migration?\u003c\/p\u003e \u003cp\u003e32.3 Countries of origin: Social, political and other reasons that trigger migration.\u003c\/p\u003e \u003cp\u003e32.4 Living conditions of migrants in the United States.\u003c\/p\u003e \u003cp\u003e32.5 Alcohol and drug use in countries of origin and receiving communities.\u003c\/p\u003e \u003cp\u003e32.6 Dependence and treatment rates.\u003c\/p\u003e \u003cp\u003e32.7 The process of migrating.\u003c\/p\u003e \u003cp\u003e32.8 Migration, substance use and access to services.\u003c\/p\u003e \u003cp\u003e32.9 Returning migrants and families left behind.\u003c\/p\u003e \u003cp\u003e32.10 Conclusions.\u003c\/p\u003e \u003cp\u003e\u003cb\u003e33\u003c\/b\u003e \u003cb\u003eEarly detection and intervention as approaches for preventing schizophrenia\u003c\/b\u003e (\u003ci\u003eMing T. Tsuang, William S. Stone, Margo Genderson and Michael Lyons\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003e33.1 Introduction.\u003c\/p\u003e \u003cp\u003e33.2 Modelling genetic and phenotypic heterogeneity.\u003c\/p\u003e \u003cp\u003e33.3 Defining a syndrome of liability using cognitive and clinical characteristics of relatives.\u003c\/p\u003e \u003cp\u003e33.4 Gene-based vs. genome-based research.\u003c\/p\u003e \u003cp\u003e33.5 Future directions.\u003c\/p\u003e \u003cp\u003e33.6 Clinical implications.\u003c\/p\u003e \u003cp\u003eAcknowledgements.\u003c\/p\u003e \u003cp\u003eReferences.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Other branches of medicine [\u003ca title=\"See our other books on Other branches of medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Other%20branches%20of%20medicine%20%5BMM%5D%22\"\u003eMM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52278022734104,"sku":"9780470694671","price":162.35,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780470694671.jpg?v=1781456095","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/textbook-of-psychiatric-epidemiology-hardback-9780470694671","provider":"Freshly Printed Books","version":"1.0","type":"link"}